Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis
A subset of cancer patients treated with immune checkpoint blockade develops colitis. Here the authors show that lower abundance of Bacteroidetes and vitamin B biosynthetic modules in fecal samples of melanoma patients can predict their susceptibility to colitis following anti-CTLA-4 treatment.
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2016-02-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/ncomms10391 |